During the course of immunotherapy, chronic stimulation of CD4+ T cells by repetitive i.n. peptide administration culminates in an altered transcriptional programme20, with pathogenic Th1 cells driven to an anergic, IL-10-secreting, regulatory phenotype21 capable of preventing autoimmunity. This evidence concerns the gene CD4 and Autoimmunity.